Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Research progress of dual-target CAR-T in China from the perspective of the ASCO 2023

Xiaobin/PharmaSourcesJune 27, 2023

Tag: Cell Therapy , CAR-T , GC012F

PharmaSources Customer Service